|
| 36938641 | Evaluating Diff-Quik cytology smears for large-panel mutation testing in lung cancer-Predicting DNA content and success with low-malignant-cellularity samples. | Cancer Cytopathol | 2023 |
| 37927461 | Discrepancies in tumor mutation burden reporting from sequential endobronchial ultrasound transbronchial needle aspiration samples within single lymph node stations - brief report. | Front Oncol | 2023 |
| 37405466 | Whole Genome Sequencing in Advanced Lung Cancer can be Performed Using Diff-Quik Cytology Smears Derived from Endobronchial Ultrasound, Transbronchial Needle Aspiration (EBUS TBNA). | Lung | 2023 |
| 37258531 | Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapy. | Nat Commun | 2023 |
| 36868206 | Australian Genomics: Outcomes of a 5-year national program to accelerate the integration of genomics in healthcare. | Am J Hum Genet | 2023 |
| 36938641 | Evaluating Diff-Quik cytology smears for large-panel mutation testing in lung cancer-Predicting DNA content and success with low-malignant-cellularity samples. | Cancer Cytopathol | 2023 |
| 37927461 | Discrepancies in tumor mutation burden reporting from sequential endobronchial ultrasound transbronchial needle aspiration samples within single lymph node stations - brief report. | Front Oncol | 2023 |
| 37258531 | Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapy. | Nat Commun | 2023 |
| 37405466 | Whole Genome Sequencing in Advanced Lung Cancer can be Performed Using Diff-Quik Cytology Smears Derived from Endobronchial Ultrasound, Transbronchial Needle Aspiration (EBUS TBNA). | Lung | 2023 |
| 36868206 | Australian Genomics: Outcomes of a 5-year national program to accelerate the integration of genomics in healthcare. | Am J Hum Genet | 2023 |
| 35057759 | Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content. | BMC Cancer | 2022 |
| 36098958 | Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes. | Cancer Discov | 2022 |
| 35637530 | Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma. | Genome Med | 2022 |
| 36147610 | Prospective Optimization of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Lymph Node Assessment for Lung Cancer: Three Needle Agitations Are Noninferior to 10 Agitations for Adequate Tumor Cell and DNA Yield. | JTO Clin Res Rep | 2022 |
| 36332611 | Shariant platform: Enabling evidence sharing across Australian clinical genetic-testing laboratories to support variant interpretation. | Am J Hum Genet | 2022 |
| 35849877 | Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels. | ESMO Open | 2022 |
| 36699384 | qmotif: determination of telomere content from whole-genome sequence data. | Bioinform Adv | 2022 |
| 35012638 | Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer. | Genome Med | 2022 |
| 34951955 | Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance. | Cancer Cell | 2022 |
| 35057759 | Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content. | BMC Cancer | 2022 |
| 35637530 | Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma. | Genome Med | 2022 |
| 35849877 | Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels. | ESMO Open | 2022 |
| 36699384 | qmotif: determination of telomere content from whole-genome sequence data. | Bioinform Adv | 2022 |
| 36147610 | Prospective Optimization of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Lymph Node Assessment for Lung Cancer: Three Needle Agitations Are Noninferior to 10 Agitations for Adequate Tumor Cell and DNA Yield. | JTO Clin Res Rep | 2022 |
| 36332611 | Shariant platform: Enabling evidence sharing across Australian clinical genetic-testing laboratories to support variant interpretation. | Am J Hum Genet | 2022 |
| 36098958 | Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes. | Cancer Discov | 2022 |
| 34951955 | Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance. | Cancer Cell | 2022 |
| 35012638 | Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer. | Genome Med | 2022 |
| 34321239 | Acquired <i>RAD51C</i> Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian Carcinoma. | Cancer Res | 2021 |
| 33514769 | Verifying explainability of a deep learning tissue classifier trained on RNA-seq data. | Sci Rep | 2021 |
| 34321239 | Acquired <i>RAD51C</i> Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian Carcinoma. | Cancer Res | 2021 |
| 33919581 | The Genomic Landscape of Lobular Breast Cancer. | Cancers (Basel) | 2021 |
| 34439402 | Correction: McCart Reed et al. The Genomic Landscape of Lobular Breast Cancer. <i>Cancers</i> 2021, <i>13</i>, 1950. | Cancers (Basel) | 2021 |
| 33514769 | Verifying explainability of a deep learning tissue classifier trained on RNA-seq data. | Sci Rep | 2021 |
| 33919581 | The Genomic Landscape of Lobular Breast Cancer. | Cancers (Basel) | 2021 |
| 34439402 | Correction: McCart Reed et al. The Genomic Landscape of Lobular Breast Cancer. <i>Cancers</i> 2021, <i>13</i>, 1950. | Cancers (Basel) | 2021 |
| 32493298 | Estimating the costs of genomic sequencing in cancer control. | BMC Health Serv Res | 2020 |
| 32493298 | Estimating the costs of genomic sequencing in cancer control. | BMC Health Serv Res | 2020 |
| 32818150 | Using whole-genome sequencing data to derive the homologous recombination deficiency scores. | NPJ Breast Cancer | 2020 |
| 33077847 | Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients. | Sci Rep | 2020 |
| 33067454 | Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity. | Nat Commun | 2020 |
| 33053644 | The Impact of Next Generation Sequencing in Cancer Research. | Cancers (Basel) | 2020 |
| 33053644 | The Impact of Next Generation Sequencing in Cancer Research. | Cancers (Basel) | 2020 |
| 33077847 | Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients. | Sci Rep | 2020 |
| 33067454 | Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity. | Nat Commun | 2020 |
| 32818150 | Using whole-genome sequencing data to derive the homologous recombination deficiency scores. | NPJ Breast Cancer | 2020 |
| 30350370 | Phenotypic and molecular dissection of metaplastic breast cancer and the prognostic implications. | J Pathol | 2019 |
| 30350370 | Phenotypic and molecular dissection of metaplastic breast cancer and the prognostic implications. | J Pathol | 2019 |
| 30178487 | Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility. | Int J Cancer | 2019 |
| 31090900 | Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers. | Ann Oncol | 2019 |